
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Hldgs is positioned for durable growth because its private-duty nursing model serves medically complex children in lower-cost home settings, making it attractive to Medicaid MCOs and less exposed to budget pressure than typical Medicaid-reimbursed peers. Management’s long-term organic revenue targets were raised to 5–6% for PDS and 8–10% for HHH, while preferred payor penetration is advancing, with PDS MCO mix at 64% in 2Q and home health episodic mix at 81%. The California Medi-Cal PDN rate increase effective January 2027, along with updated 2026 adjusted EBITDA of $370.7MM and 2027 adjusted EBITDA of $400.6MM, reinforces visibility into stronger volumes, margin expansion, and free cash flow generation.
Bears say
Aveanna Healthcare Hldgs is facing a negative fundamental setup because labor headwinds are assumed to reduce the base case FY27 adjusted EBITDA estimate by 10%, indicating sustained margin pressure in its labor-intensive home care model. Its dependence on Medicaid and Medicaid MCO reimbursement heightens vulnerability if legislative rate initiatives and the company’s preferred payor strategy stall, limiting revenue improvement and pricing leverage. With the multiple retreating to approximately 8x the downside EBITDA estimate, the data imply weak earnings durability and limited valuation support if operational and reimbursement challenges persist.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Aveanna Healthcare Holdings (AVAH) Forecast
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares